Literature DB >> 7002295

Mutagenicity of hydroxamic acids and the probable involvement of carbamoylation.

P L Skipper, S R Tannenbaum, W G Thilly, E E Furth, W W Bishop.   

Abstract

A series of hydroxamic acids (aceto-, propiono-, benzo-, and p-nitrobenzo-) and seven derivatives of these were examined for biological activity using Salmonella typhimurium. Acylation to yield O-acetyl and O-benzoyl derivatives markedly enhanced toxic properties and was necessary for mutagenic activity for all but p-nitrobenzohydroxamic acid. The dose necessary to produce a minimum significant mutagenic response varied from 21 microM for O-benzoyl benzohydroxamate to 430 microM for O-acetyl acetohydroxamate. These two compounds were also tested with human lymphoblasts to which they were toxic at 100 microM but not mutagenic. O-Acetyl benzohydroxamate, a mutagen, was prepared wih a 14C label in the carbonyl carbon atom of the benzoyl group and was shown to form an adduct in vitro with DNA and polyguanylic acid. The level of binding was 1 mol of 14C per 5 X 10(4) mol of DNA phosphate and 1 mol of 14C per 10(5) mol of polyguanylic acid phosphate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002295

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?

Authors:  Sida Shen; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2015-11-25       Impact factor: 3.466

2.  Results of in vitro and in vivo genetic toxicity tests on methyl isocyanate.

Authors:  M D Shelby; J W Allen; W J Caspary; S Haworth; J Ivett; A Kligerman; C A Luke; J M Mason; B Myhr; R R Tice
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

3.  Small molecule inhibition of apicomplexan FtsH1 disrupts plastid biogenesis in human pathogens.

Authors:  Katherine Amberg-Johnson; Sanjay B Hari; Suresh M Ganesan; Hernan A Lorenzi; Robert T Sauer; Jacquin C Niles; Ellen Yeh
Journal:  Elife       Date:  2017-08-18       Impact factor: 8.140

4.  Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors.

Authors:  Giuseppe Campiani; Caterina Cavella; Jeremy D Osko; Margherita Brindisi; Nicola Relitti; Simone Brogi; A Prasanth Saraswati; Stefano Federico; Giulia Chemi; Samuele Maramai; Gabriele Carullo; Benedikt Jaeger; Alfonso Carleo; Rosaria Benedetti; Federica Sarno; Stefania Lamponi; Paola Rottoli; Elena Bargagli; Carlo Bertucci; Daniele Tedesco; Daniel Herp; Johanna Senger; Giovina Ruberti; Fulvio Saccoccia; Simona Saponara; Beatrice Gorelli; Massimo Valoti; Breándan Kennedy; Husvinee Sundaramurthi; Stefania Butini; Manfred Jung; Katy M Roach; Lucia Altucci; Peter Bradding; David W Christianson; Sandra Gemma; Antje Prasse
Journal:  J Med Chem       Date:  2021-07-12       Impact factor: 8.039

5.  Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [18F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain.

Authors:  Oliver Clauß; Linda Schäker-Hübner; Barbara Wenzel; Magali Toussaint; Winnie Deuther-Conrad; Daniel Gündel; Rodrigo Teodoro; Sladjana Dukić-Stefanović; Friedrich-Alexander Ludwig; Klaus Kopka; Peter Brust; Finn K Hansen; Matthias Scheunemann
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.